Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > bid and ask (manipulation? who knows)

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Dec 20, 2023 7:38pm

207 Views

Post# 35794875

RE:RE:RE:bid and ask (manipulation? who knows)

And you wonder how many of the 15 or so that started as CR or IR and trending to NR would have benefited with an additional treatment at Day 270. Sometimes, you want the earth to spin a little faster to get to the review and decision. Hope the FDA or HCA don't add more obstacles to hurdle over. Would almost be criminal. Let's hope they put out a compelling EOY release with data arranged like you have. Keeps the last round of investors interested when the next round comes up in Jan or early Feb.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec